STOCK TITAN

If You Invested in Atlantic Coastal Acquisition Corp. II (ACAB)

Biological Products, (no Disgnostic Substances) · NASDAQ
Looking for the current price? See the ACAB quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2022-03-09
$1,000 invested 5 Years Ago
N/A
Trading since 2022-03-09

What $1,000 or $10,000 in ACAB Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Mar 9, 2022
$1,000 $583 -42%
$10,000 $5,828 -42%

Based on real historical closing prices, dividend- and split-adjusted, through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for ACAB

$1,000 Investment Over Time

ACAB vs S&P 500

Year-by-Year Returns

ACAB annual performance
Year Start Price End Price Annual Return Cumulative
2022 $9.90 $10.19 +2.9% +2.9%
2023 $10.20 $10.58 +3.7% +6.9%
2024 $10.58 $5.77 -45.5% -41.7%

About Atlantic Coastal Acquisition Corp. II

Biological Products, (no Disgnostic Substances) · NASDAQ

Market Cap
$0.1B
Current Price
$5.77
View full ACAB overview

Frequently Asked Questions

Atlantic Coastal Acquisition Corp. II investment returns

How much would $1,000 invested in Atlantic Coastal Acquisition Corp. II be worth today?

Limited historical data is available for ACAB. The stock has been trading since 2022-03-09.

Has Atlantic Coastal Acquisition Corp. II outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare ACAB performance over available time periods.

What is Atlantic Coastal Acquisition Corp. II's average annual return?

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.